Threestones Capital Logo
Dataroom Access

Investor Documents

Access Key Investor Information Documents and fund documentation for investors.

 
Threestones MIPIM Team

Threestones Capital at MIPIM 2023

Threestones Capital had a successful week at MIPIM 2023 in Cannes, France. We would like to express our sincere gratitude to our partners, clients, and friends who visited our stand during the event. We are pleased to note the growing interest in healthcare real estate, and we welcome the opportunity to discuss our solutions with those who share our passion.

During the conference our Founding Partner, Alessandro Sparaco, engaged with industry leaders and shared insights on the latest trends in healthcare real estate during the Healthcare Workshop organized by MIPIM.

Additionally, Threestones Capital partnered with the Savills Operational Capital Markets team to host a Healthcare Matchmaking Event that brought together healthcare real estate professionals from all over Europe.

Finally, we were proud to see Alessandro Sparaco presenting the prize for “Best Alternative Project” to the Deloitte University EMEA at the MIPIM Awards ceremony. This was a great honour for Threestones Capital and we congratulate all the winners.

We look forward to continued growth and success in the healthcare real estate industry, and we appreciate MIPIM 2023 for providing the opportunity to connect with fellow professionals and showcase our solutions.

Threestones Capital
[email protected]

Threestones Capital Management S.A. is an authorized Alternative Investment Fund Manager (AIFM) headquartered in Luxembourg. The company manages approximately EUR 2 billion in four Real Estate regulated investment vehicles under the supervision of the Luxembourg financial authorities (CSSF), in compliance with European financial regulations. Founded in 2009, Threestones Capital primarily focuses on real estate investments across Europe, targeting healthcare real estate. The company’s investors are a diverse mix of family offices and institutional investors. Investor Relations: [email protected]



Cookie Settings